Fundraising FoxNexo Therapeutics, Inc.
Littleton, US · Founded 2022 · Delaware corporation · 2 known investors
Find your way into Nexo Therapeutics, Inc.
Sign up to see every warm intro you have to Nexo Therapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nexo Therapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AP
Andrew PhillipsExecutiveAndrew Phillips holds a bachelor's degree in pharmaceutical product development with minors in biology and chemistry from West Chester University, and has prior experience in the discovery, optimization, production, and purification of therapeutic antibodies using molecular biology and cell culture techniques.
Board
AB
CR
Investors · 2
New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40Mvia Ali Behbahani · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Versant VenturesreportedSan Francisco · $250K – $5Mvia Carlo Rizzuto · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$60M disclosed across 1 round · 2022
▶$60MraisedMar 2026 · 7 investors · BiotechnologyRule 506(b)
▶$60MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ali BehbahaniDirector
- Andrew PhillipsExecutive Officer, Director
- Carlo RizzutoDirector
- Offering amount
- $60M
- Amount sold
- $60M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Nexo Therapeutics, Inc.'s investors?
- Nexo Therapeutics, Inc.'s investors include New Enterprise Associates (NEA), Versant Ventures.
- How much funding has Nexo Therapeutics, Inc. raised?
- Nexo Therapeutics, Inc. has disclosed $60M raised across 1 round.
- Where is Nexo Therapeutics, Inc. headquartered?
- Nexo Therapeutics, Inc. is headquartered in Littleton, US.